8 results
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... #BLUE #protocol ... #Algorithm #Dyspnea ... #CriticalCare # ... POCUS #Lung #Pulmonary
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... , a half B-profile ... #protocol #Algorithm ... #Dyspnea #CriticalCare ... #POCUS #Lung #Pulmonary
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... the ICU The BLUE-protocol ... B profile is a half ... , a half B-profile ... /11924/dyspnea-criticalcare-pulmonary-algorithm-pocus
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
• Amiodarone half ... starting amiodarone treatment ... Exclude other causes ... macrophages Treatment ... #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... the determined cause ... #differential #algorithm ... #management #cardiology ... heartfailure #chf #criticalcare
Perhaps quite too often, the knee-jerk reaction to an elevated Troponin is to call our friends
Troponin is to call ... #diagnosis #algorithm ... echocardiogram #management ... #clinical #criticalcare ... #foamed #treatment
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Most cases are related ... JAK2, CALR-calreticulin ... • Treatment algorithms ... #diagnosis #management ... #hematology
Anti-NXP-2 Dermatomyositis

What?
DM with generalized subcutaneous edema
Pts have more myalgias, more severe weakness, and an increased prevalence
Periorbital heliotrope (blue-purple ... Muscle atrophy may cause ... positive patients Treatment ... Dermatomyositis #diagnosis #management ... #rheumatology #dermatology